With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Phase I Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors||Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Georgia|
|HA-1 TCR T-cell Immunotherapy for Acute Leukemia||Fred Hutchinson Cancer Research Center / Marie Bleakley, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Washington|
|DNA Methylation Inhibitor Therapy for Testicular Germ Cell Tumors||University of Illinois, Urbana-Champaign / Michael Spinella, Ph.D.||Reach Grants||2014||Illinois|
|Targeted Inhibition of the DNA Damage Response Pathway: A Novel Intervention in the Treatment of Pediatric Leukemias||National Cancer Institute / Andre Nussenzweig, Ph.D.||Reach Grants||2014||Maryland|
|A Novel Target for Neuroblastoma Treatment||Beckman Research Institute of City of Hope / Linda Malkas, Ph.D.||Reach Grants||2014||California|
|Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma||The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D.||Reach Grants||2014||California|
|Identification of Rhabdomyosarcoma Therapies Using an Efficient Mouse and Drosophila Repurposing Screen||Memorial Sloan-Kettering Cancer Center / Mary Baylies, Ph.D.||Reach Grants||2014||New York|
|Targeting eEF2 Kinase in Neuroblastoma||University of California San Francisco / William Weiss, M.D., Ph.D.||Innovation Grants||2014||California|
|Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells||Children's Hospital of Philadelphia / Mitchell Weiss, M.D., Ph.D.||Innovation Grants||2014||Pennsylvania|
|Targeting the Accomplices of MYC in MYC-driven Medulloblastoma||Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D.||Innovation Grants||2014||California|